Haemonetics (HAE) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Haemonetics (HAE) is Neutral.

The composite score behind that read is +0.18, weighing +0.24 of bullish evidence against -0.38 bearish.

Haemonetics last closed at $118.69, -0.65% on the session.

Against the IVW growth benchmark the position is -1.45% over the forecast window.

The read is built from 15 underlying insights — 9 bullish and 6 bearish.

Agreement across those insights is 40%.

1 graded prediction for HAE so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Haemonetics in the 12th percentile on valuation and the 64th percentile on return on equity, where 100 is best.

Haemonetics is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $5.44B.

StockMap tracks Haemonetics as the 29th largest of the 140 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 122 Neutral, 16 Moderate Underperform and 2 Moderate Outperform.

On that composite Haemonetics ranks 3rd of 140 in the group, against a group median of -0.03.